These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32898178)

  • 1. The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
    Vogel OA; Han J; Liang CY; Manicassamy S; Perez JT; Manicassamy B
    PLoS Pathog; 2020 Sep; 16(9):e1008842. PubMed ID: 32898178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T; Kawahara Y
    Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
    PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
    Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
    J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.
    Zhou S; Yang C; Zhao F; Huang Y; Lin Y; Huang C; Ma X; Du J; Wang Y; Long G; He J; Liu C; Zhang P
    J Biol Chem; 2019 Nov; 294(48):18168-18180. PubMed ID: 31636123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway.
    Zhang H; Ni G; Damania B
    Cell Rep; 2020 Apr; 31(4):107564. PubMed ID: 32348766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.
    Ward SV; George CX; Welch MJ; Liou LY; Hahm B; Lewicki H; de la Torre JC; Samuel CE; Oldstone MB
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):331-6. PubMed ID: 21173229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T; Kawahara Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
    Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
    Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas.
    Yang B; Hu P; Lin X; Han W; Zhu L; Tan X; Ye F; Wang G; Wu F; Yin B; Bao Z; Jiang T; Yuan J; Qiang B; Peng X
    Cell Mol Life Sci; 2015 Nov; 72(22):4383-97. PubMed ID: 26047657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
    Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
    Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
    J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection.
    Jiang Z; Wei F; Zhang Y; Wang T; Gao W; Yu S; Sun H; Pu J; Sun Y; Wang M; Tong Q; Gao C; Chang KC; Liu J
    Nat Microbiol; 2021 Jul; 6(7):932-945. PubMed ID: 33986530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR1: "Editor-in-Chief" of Cytoplasmic Innate Immunity.
    Lamers MM; van den Hoogen BG; Haagmans BL
    Front Immunol; 2019; 10():1763. PubMed ID: 31404141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
    Liu G; Lu Y; Liu Q; Zhou Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
    Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
    J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I Proteins.
    Rahim MMA; Parsons BD; Price EL; Slaine PD; Chilvers BL; Seaton GS; Wight A; Medina-Luna D; Dey S; Grandy SL; Anderson LE; Zamorano Cuervo N; Grandvaux N; Gaglia MM; Kelvin AA; Khaperskyy DA; McCormick C; Makrigiannis AP
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication.
    de Chassey B; Aublin-Gex A; Ruggieri A; Meyniel-Schicklin L; Pradezynski F; Davoust N; Chantier T; Tafforeau L; Mangeot PE; Ciancia C; Perrin-Cocon L; Bartenschlager R; André P; Lotteau V
    PLoS Pathog; 2013; 9(7):e1003440. PubMed ID: 23853584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
    Pfaller CK; Donohue RC; Nersisyan S; Brodsky L; Cattaneo R
    PLoS Biol; 2018 Nov; 16(11):e2006577. PubMed ID: 30496178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.